The institutional landscape for SAB Biotherapeutics, Inc. (NASDAQ:SABS) includes 48 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 31 Dec, 2025 | 11,420,000 | 0 | 0.00% | $42,710,800.00 |
| Commodore Capital LP | 31 Dec, 2025 | 4,401,500 | 0 | 0.00% | $16,461,610.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 4,401,500 | 0 | 0.00% | $16,461,610.00 |
| Woodline Partners LP | 31 Dec, 2025 | 2,850,881 | 0 | 0.00% | $10,662,295.00 |
| Spruce Street Capital LP | 31 Dec, 2025 | 2,198,502 | 2,198,502 | 0.00% | $8,222,397.00 |
| Sessa Capital IM, L.P. | 31 Dec, 2025 | 2,198,457 | 0 | 0.00% | $8,222,229.00 |
| Blackstone Inc. | 31 Dec, 2025 | 2,143,585 | 2,143,585 | 0.00% | $8,017,008.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,847,136 | 1,481,383 | 405.02% | $6,908,288.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 803,210 | 803,210 | 0.00% | $3,004,005.00 |
| Propel Bio Management, LLC | 31 Dec, 2025 | 652,881 | 652,881 | 0.00% | $2,441,775.00 |
| Jefferies Financial Group Inc. | 31 Dec, 2025 | 580,328 | 580,328 | 0.00% | $2,170,427.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 475,439 | 475,439 | 0.00% | $1,778,142.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 324,090 | 324,090 | 0.00% | $1,212,097.00 |
| HB Wealth Management, LLC | 31 Dec, 2025 | 307,500 | 0 | 0.00% | $1,150,050.00 |
| AMERIPRISE FINANCIAL INC | 31 Dec, 2025 | 283,645 | 283,645 | 0.00% | $1,060,833.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 236,460 | 236,460 | 0.00% | $884,360.00 |
| Simplify Asset Management Inc. | 31 Dec, 2025 | 208,227 | 208,227 | 0.00% | $778,769.00 |
| AWM Investment Company, Inc. | 31 Dec, 2025 | 200,000 | 0 | 0.00% | $748,000.00 |
| STEMPOINT CAPITAL LP | 31 Dec, 2025 | 146,558 | 146,558 | 0.00% | $548,127.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 119,517 | 33,799 | 39.43% | $447,037.00 |